Product Images Selexipag Titration Pack

This text provides information on the Kaplan-Meier analysis for patients event-free percentage, hazard ratio, and statistical significance. The hazard ratio of 0.60 suggests a lower risk in the treatment group compared to the placebo group. The p-value being less than 0.0001 indicates a statistically significant difference between the treatment and placebo groups. The data also includes the number of patients at risk over time for both the Selexipag and placebo groups.*

This text provides a comparison between Selexipag and Placebo patients at different time points measured in months from randomization. It includes the number of patients at risk at each time point for both groups.*

This text provides details about Selexipag tablets, each containing 200 mcg of selexpag. It includes information on dosage, storage conditions, manufacturer, and a reminder to keep drugs out of reach of children. The text also mentions a coding template and the specific size of the tablets.*

This text provides information about a medication called Selexipag. It contains 400 mcg tablets and includes important details such as dosage, storage instructions, and manufacturer (Zydus). The package is child-resistant and patients are advised to keep the tablets away from children. The NDC code for the medication is 70771-1794-6.*

This is a description of a Gver Coding Template. It contains 60 tablets, each coated and containing 600 mcg of a substance. The package includes information about dosage, storage conditions, child-resistant packaging, and a reminder to keep all drugs out of the reach of children. The manufacturer is identified as 2yd@ Gl.*

This text is a product label for Gver Coding Template tablets. Each film-coated tablet contains 800 mcg of selexipag. It is advised to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F). The package is child-resistant and contains 60 tablets. The usual dosage information can be found in the package insert. The label also includes a warning to keep all drugs out of the reach of children.*

This is a description for a medication package labeled with 60 tablets of 1000mg each. The medication is in the form of coated tablets with prescribing information included. It is advised to store the medication at a temperature between 20°C to 25°C (68°F to 77°F), and to keep it out of reach of children as the package is child-resistant.*

This text describes a packaging label for Selexipag tablets, containing 60 tablets with a dosage of 1200 mcg per tablet. It provides instructions to read the prescribing information before use, store at a controlled room temperature, ensure child-resistant packaging, and keep all drugs out of reach of children. The tablets are manufactured by Zydus Lifesciences Ltd. in India.*

This text is a label for Gver Coding Template containing Selexipag tablets. The label includes dosage instructions, storage conditions, and precautions for child safety. Each film-coated tablet contains Selexipag. The package contains 60 tablets and must be stored at a temperature between 20°C to 25°C. Additionally, it emphasizes keeping the package and all drugs out of the reach of children. *

This text appears to be a description of a medication product - Selexipag Tablets. The tablets are available in two strengths: 200 mcg and 800 mcg. The packaging includes 140 tablets for the 200 mcg strength and 60 tablets for the 800 mcg strength. It is recommended to read the prescribing information before use and store the tablets at a temperature between 20°C to 25°C. The manufacturer is mentioned as Zydus Lifesciences Ltd. from Ahmedabad, India. Additionally, the text provides details on the National Drug Code (NDC) for the product and emphasizes keeping the medication out of reach of children.*